A Study to Assess the Equivalence Dose Plans & Efficiency Benefits of the UroNAV High Dose Rate (HDR) Brachytherapy Ultrasound Planning System for Treatment of Prostate Cancer


  • Study type

  • Study IDs

  • Describes the nature of a clinical study. Types include:

    • Observational study — observes people and measures outcomes without affecting results.
    • Interventional study (clinical trial) — studies new tests, treatments, drugs, surgical procedures or devices.
    • Medical records research — uses historical information collected from medical records of large groups of people to study how diseases progress and which treatments and surgeries work best.
  • Site IRB
    • Rochester, Minnesota: 17-006580
    Sponsor Protocol Number: 17-006580

About this study

The purpose of this study is to compare the UroNav-HDR Brachytherapy system with the current standard operating procedure, which uses either Computed Tomography (CT) or Ultrasound (US) imaging for needle reconstruction and radiotherapy treatment planning.     

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.

See eligibility criteria

Inclusion Criteria:

  • Men 
  • Ages 40-85

Exclusion Criteria: 

  • None

Participating Mayo Clinic locations

Study statuses change often. Please contact us for help.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Lance Mynderse, M.D.

Contact us for the latest status

Contact information:

Justine Buroker M.B.A., CCRP



More information


Publications are currently not available

Study Results Summary

Not yet available

Supplemental Study Information

Not yet available


Mayo Clinic Footer